164
Participants
Start Date
December 13, 2018
Primary Completion Date
November 2, 2022
Study Completion Date
November 2, 2022
Placebo Oral Tablet
Placebo oral tablet
AGB101 220 mg tablet
220 mg AGB101 active compound
Richmond Behavioral Associates, Staten Island
Neurological Associates of Albany PC, Albany
Johns Hopkins University School of Medicine, Baltimore
Clinical Biotechnology Research Institute at RSFH, Charleston
NeuroStudies.net, LLC, Decatur
Bioclinica Research, Orlando
MD Clinical, Hallandale
Miami Jewish Health, Miami
IMIC Research, Palmetto Bay
Boynton Beach Medical Research Institite, Boynton Beach
Brain Matters Research, Delray Beach
The Roskamp Institute, Inc, Sarasota
Brain Matters Research, Stuart
Memory Center/Hattiesburg Clinic, Hattiesburg
Great Lakes Clinical Trials, Chicago
Clinical Research Professionals, Chesterfield
The Mile High Research Center, Denver
Banner Alzheimer's Institute, Phoenix
Excell Research Inc, Oceanside
Senior Clinical Trials, Inc., Laguna Hills
The NeuroCognitive Institute, Mount Arlington
Global Medical Institutes LLC; Princeton Medical Institute, Princeton
Neurology Specialist of Monmouth County, PA, West Long Branch
Toronto Memory Program, Toronto
Lead Sponsor
National Institute on Aging (NIA)
NIH
AgeneBio
INDUSTRY